Agitation: Conceptualization, measurement, and treatment

Bulletin of the Menninger Clinic

Volumn 63, Issue 2 SUPPL. A, 1999, Pages

  Kopecky, Heather J ^a   Yudofsky, Stuart C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PROPRANOLOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID;

AFFECTIVE NEUROSIS; AGING; AGITATION; BONE MARROW SUPPRESSION; CAREGIVER; COGNITIVE THERAPY; CONCEPT FORMATION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG HALF LIFE; DRUG MECHANISM; EMOTION; HUMAN; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; RATING SCALE; REVIEW; SOCIAL ISOLATION; TARDIVE DYSKINESIA;

EID: 0032911484     PISSN: 00259284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Alexopoulous, G. S., Silver, J. M., Kahn, D. A., Frances, A., & Carpenter, D. (Eds.). (1998). Treatment of agitation in older persons with dementia: A postgraduate medicine special report. Minneapolis, MN: McGraw-Hill.
2. Ancill, R. J., Embury, G. D., MacEwan, G. W., & Kennedy, J. S. (1988). The use and misuse of psychotropic prescribing for elderly psychiatric patients. Canadian Journal of Psychiatry, 33(7), 585-589.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Aronson, M. K., Post, D. C., & Guastadisegni, P. (1993). Dementia, agitation, and care in the nursing home. Journal of the American Geriatrics Society, 41, 507-512.
5. Avorn, J., Soumerai, S. B., Everitt, D. E., Ross-Degnan, D., & Beers, M. (1992). A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. New England Journal of Medicine, 327, 168-173.
6. Barnes, R., & Raskind, M. (1980). Strategies for diagnosing and treating agitation in the aging. Geriatrics, 35, 111-119.
7. Beers, M., Avorn, J., & Soumerai, S. B. (1988). Psychoactive medication use in intermediate care facility residents. JAMA, 260, 3016-3020.
8. Bernstein, L. R., Folkman, S., & Lazarus, R. S. (1989). Characterization of the use and misuse of medications by an elderly, ambulatory population. Medical Care, 27(6), 654-663.
9. Billig, N., Cohen-Mansfield, J., & Lipson, S. (1991). Pharmacological treatment of agitation in a nursing home. Journal of the American Geriatrics Society, 39, 1002-1005.
10. Bogner, J., & Corrigan, J. D. (1995). Epidemiology of agitation following brain injury. Neurorehabilitation, 5, 293-297.
11. Brooke, M. M., Questad, K. A., Patterson, D. R., & Bashak, K. J. (1992). Agitation and restlessness after closed-head injury: A prospective study of 100 consecutive admissions. Archives of Physical Medicine and Rehabilitative Medicine, 73, 320-323.
12. Bross, M. H., & Tatum, N. O. (1994). Delirium in the elderly patient. American Family Physician, 50, 1325-1332.
13. Buck, J. A. (1988). Psychotropic drug practices in nursing homes. Journal of the American Geriatrics Society, 36, 409-418.
14. Burney-Puckett, M. (1996). Sundown syndrome: Etiology and management. Journal of Psychosocial Nursing, 34, 40-43.
15. Chandler, J. D., & Chandler, J. E. (1988). The prevalence of neuropsychiatric disorders in a nursing home population. Journal of Geriatric Psychiatry and Neurology, 1, 71-76.
16. Cohen-Mansfield, J. (1995). Assessment of disruptive behavior/agitation in the elderly: Function, methods, & difficulties. Journal of Geriatric Psychiatry and Neurology, 8, 52-60.
17. Cohen-Mansfield, J. (1986). Agitated behaviors in the elderly: Preliminary results in the cognitively deteriorated. Journal of the American Geriatrics Society, 34, 722-727.
18. Cohen-Mansfield, J., & Billig, N. (1986), Agitated behavior in the elderly: A conceptual review. Journal of the American Geriatrics Society, 34, 711-721.
19. Cohen-Mansfield, J., & Marx, M. S. (1990). The relationship between sleep disturbances and agitation in a nursing home. Journal of Aging and Health, 2(1), 42-57.
20. Cohen-Mansfield, J., Marx, M. S., & Werner, P. (1992). Agitation in elderly persons: An integrative report of findings in a nursing home. International Psychogeriatrics, 4, 221-239.
21. Devanand, D. P., & Levy, S. R. (1995). Neuroleptic treatment of agitation and psychosis in dementia. Journal of Geriatric Psychiatry and Neurology, 8(Suppl. 1), S18-S27.
22. Dyck, G. (1997). Management of geriatric behavior problems. Psychiatric Clinics of North America, 20(1), 165-180.
23. Fawcett, J., Marcus, R. N., Anton, S. F., O'Brien, K., & Schwiderski, U. (1995). Response of anxiety and agitation symptoms during nefazadone treatment of major depression. Journal of Clinical Psychiatry, 56, 37-42.
24. Friedman, R., Gryfe, C. I., Tal, D. T., et al. (1992). The noisy elderly patient: Prevalence, assessment, and response to the antidepressant doxepin. Journal of Geriatric Psychiatry and Neurology, 5, 187-190.
25. Gallop, R., Lancee, W., & Shugar, G. (1993). Residents' and nurses' perceptions of difficult-to-treat short-stay patients. Hospital and Community Psychiatry, 44, 352-357.
26. Giakas, W. J., Seibyl, J. P., & Mazure, C. M. (1990). Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. Journal of Clinical Psychiatry, 51, 115-118.
27. Galski, T., Palsz, J., Bruno, R. L., & Walker, J. E. (1994). Predicting physical and verbal aggression on a brain trauma unit. Archives of Physical and Medical Rehabilitation, 75, 380-383.
28. Garrard, J., Dunham, T., Makris, L., Cooper, S., & Heston, L. (1992). Longitudinal study of psychotropic drug use by elderly nursing home residents. Journal of Gerontology, 47, M183-M188.
29. Garrard, J., Makris, L., Dunham, T., Heston, L. L., Cooper, S., Ratner, E. R., Sellerman, D., & Kane, R. L. (1991). Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. Journal of the American Medical Association, 265, 463-467.
30. Gerdner, L. (1997). An individualized music intervention for agitation. Journal of the American Psychiatric Nurses Association, 3, 177-184.
31. Gurwitz, J. R., Soumerai, S. B., & Avorn, J. (1990). Improving medication prescribing and utilization in nursing homes. Journal of the American Geriatrics Society, 38, 542-552.
32. Hall, G. R., Buckwalter, K. C., Stolley, J. M., Gerdner, L. A., Garand, L., Ridgeway, S., & Crump, S. (1995). Standardized care plan: Managing Alzheimer's patients at home. Journal of Gerontologic Nursing, 21(1), 37-47.
33. Hamel, M., Gold, D. P., Andres, D., Reis, M., Dastour, D., Grauer, H., & Bergman, H. (1990). Predictors and consequences of aggressive behavior by community-based dementia patients. Gerontologist, 30, 206-211.
34. Harrington, C., Tompkins, C., Curtis, M., & Grant, L. (1992). Psychotropic drug use in long-term care facilities. Gerontologist, 32, 833-839.
35. Jacobson, S., & Schreibman, B. (1994). Behavioral and pharmacologic treatment of delirium. American Family Physician, 56(8), 2005-2012.
36. Jencks, S. F., & Clauser, S. B. (1991). Managing behavior problems in nursing homes. JAMA, 265, 502-506.
37. Institute of Medicine Committee on Nursing Home Regulations. (1986). Improving the quality of care in nursing homes. Washington, DC: National Academy Press.
38. Kahn, D., Stevenson, E., & Douglas, C. J. (1988). Effect of sodium valproate in three patients with organic brain syndromes. American Journal of Psychiatry, 145, 1010-1011.
39. Kirby, M., & Lawlor, B. A. (1995). Biologic markers and neurochemical correlates of agitation and psychosis in dementia. Journal of Geriatric Psychiatry and Neurology, 8(1), S2-S7.
40. Kopecky, H. J., Kopecky, C. R., & Yudofsky, S. C. (1998). Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients. Psychiatric Quarterly, 69(4), 301-322.
41. Kunik, M. E., Yudofsky, S. C., Silver, J. M., & Hales, R. E. (1994). Pharmacologic approach to the management of agitation associated with dementia. Journal of Clinical Psychiatry, 55(2), 13-17.
42. Lantz, M. S., & Marin, D. (1996). Pharmacologic treatment of agitation in dementia: A comprehensive review. Journal of Geriatric Psychiatry and Neurology, 9, 107-119.
43. Lebert, F., Pasquier, F., & Petit, H. (1994). Behavioral effects of trazodone in Alzheimer's disease. Journal of Clinical Psychiatry, 55, 536-538.
44. Lehninger, F. W., Ravindran, V. L., & Stewart, J. T. (1998). Management strategies for problem behaviors in the patient with dementia. Geriatrics, 53(4), 55-75.
45. Lemke, M. R. (1995). Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. Journal of Clinical Psychiatry, 56, 354-357.
46. Levy, R. H. (1996). Sedation in acute and chronic agitation. Pharmacotherapy, 16(6), 152S-159S.
47. Marx, M. S., Cohen-Mansfield, J., & Werner, P. (1990). Agitation and falls in institutionalized elderly persons, Journal of Applied Gerontology, 9(1), 106-117.
48. Mellow, A. M., Solano-Lopez, C., & Davis, S. (1993). Sodium valproate in the treatment of behavioral disturbance in dementia. Journal of Geriatric Psychiatry and Neurology, 6, 205-209.
49. Mungas, D., Weiler, P., Franzi, C., & Henry, R. (1989). Assessment of disruptive behavior associated with dementia: The Disruptive Behavior Rating Scales. Journal of Geriatric Psychiatry and Neurology, 2, 196-202.
50. Naimark, D., Jackson, E., Rockwell, E., & Jeste, D. V. (1996). Psychotic symptoms in Parkinson's disease patients with dementia. Journal of the American Geriatrics Society, 44, 296-299.
51. Nygaard, H. A., Bakke, K., Brudvik, E., Elgen, K., & Lien, G. K. (1994). Dosing of neuroleptics in elderly demented patients with aggressive and agitated behavior: A double-blind study w th Zuclopenthixol. Current Medical Research and Opinion, 13, 222-232.
52. O'Brien, J., Doane, K. W., & Risse, S. C. (1991). Reduction of neuroleptic drug use in nursing homes through nursing-oriented pharmacy consultation. Consulting Pharmacology, 6, 538-542.
53. Okawa, M., Mishima, K., Hishikawa, Y., Hozumi, S., et al. (1991). Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep, 14, 478-485.
54. Patterson, T. S., & Sargent, M. (1990). Behavioral management of the agitated head trauma client. Rehabilitation Nursing, 15, 248-249.
55. Pies, E. (1993, October). A symptom in search of a diagnosis. Psychiatric Times, pp. 18-19.
56. Pozuelo, L., Franco, K., & Palmer, R. (1998). Agitated dementia: Drug vs. nondrug treatment. Cleveland Clinic Journal of Medicine, 65(4), 191-199.
57. Ratey, J. J., Leveroni, C L., Miller, A. C., et al. (1992). Low-dose buspirone to treat agitation and maladaptive behavior in brain-injured patients: Two case reports. Journal of Clinical Psychopharmacology, 12, 362-364.
58. Ray, W. R., Taylor, J. A., Meador, K. G., et al. (1993). Reducing anti-psychotic drug use in nursing homes. Archives of Internal Medicine, 153, 713-721.
59. Roper, J. M., Shapiro, J, & Chang, B. L. (1991). Agitation in the demented patient: A framework for management. Journal of Gerontologie Nursing, 17, 17-21.
60. Sandel, M. E., Zwil, A. S., & Fugate, L. P. (1995). An interdisciplinary perspective on the agitated brain-in ured patient. Neurorehabilitation, 5, 299-308.
61. Schatzberg, A. F. (1991). Overview of anxiety disorders: Prevalence, biology, course, and treatment. Journal of Clinical Psychiatry, 52(Suppl., July), 5-9.
62. Semla, T. P., Palla, K., Poddig, B., & Brauner, P. J. (1994). Effect of the Omnibus Reconciliation Act on antipsychotic prescribing in nursing home residents. Journal of the American Geriatrics Society, 42, 648-652.
63. Silver, J. M., Hales, R. E., & Yudofsky, S. C. (1997). Neuropsychiatrie aspects of traumatic brain injury. In S. C. Yudofsky & R. E. Hales (Eds.), The American Psychiatric Press textbook of neuropsychiatry (3rd ed.). Washington, DC: American Psychiatric Press.
64. Silver, J. M., Yudofsky, S., Kogan, M., et al. (1986). Elevation of thioridazine plasma levels by propranolol. American Journal of Psychiatry, 143, 1290-1292.
65. Sinha, D., Zemlan, F. P., Nelson, S., Bienenfold, D., Thienhaus, O., Ramaswarny, G., & Hamilton, S. (1992). A new scale for assessing behavioral agitation in dementia. Psychiatry Research, 41, 73-88.
66. Smith-Jones, S. M., & Francis, G. M. (1992). Disruptive, institutionalized elderly: A cost-effective intervention. Journal of Psychosocial Nursing, 30, 17-20.
67. Stanislav, S. W., Fabre, T., Crismon, M. L., et al. (1994). Buspirone's efficacy in organic-induced aggression, Journal of Clinical Psychopharmacology, 143, 1290-1292.
68. Stewart, J. T. (1995). Management of behavior problems in the demented patient. American Family Physician, 52, 2312-2317.
69. Struble, L. M., & Siversten, L. (1987). Agitation behaviors in confused elderly patients. Journal of Gerontological Nursing, 13, 40-44.
70. Tariot, P. N. (1996). Treatment strategies for agitation and psychosis in dementia. Journal of Clinical Psychiatry, 57(Suppl. 14), 21-29.
71. Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L, & Irvine, C. (1998). Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. American Journal of Psychiatry, 155, 54-61.
72. Tariot, P. N., Schneider L. S., & Katz I. R. (1995). Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. Journal of Geriatric Psychiatry and Neurology, 8(Suppl. 1), S28-S39.
73. Thapa, P. B., Brockman, K. G., Gideon, P., Fought, R. L., & Ray, W. A. (1996). Injurious falls in nonambulatory nursing home residents: A comparative study of circumstances, incidence, and risk factors. Journal of the American Geriatrics Society, 44, 273-278.
74. Thomas, D. R. (1988). Assessment and management of agitation in the elderly. Geriatrics, 43, 45-53.
75. Tueth, M. J. (1995). Dementia: Diagnosis and emergency behavioral complications. Journal of Emergency Medicine, 13(4), 519-525.
76. Weick, M. D. (1992, November). Physical restraints: An FDA update. American Journal of Nursing, pp. 74-80.
77. Wilcox, S. M., Himmelstein, O. U., & Woolhandler, S. (1994). Inappropriate drug prescribing for the community dwelling elderly. JAMA, 272(4), 292-295.
78. Wolf, A. P., Gleckman, A. D., Cifu, D. X., & Ginsburg, P. C. (1996). The prevalence of agitation and brain injury in skilled nursing facilities: A survey. Brain Injury, 10(4), 241-245.
79. Yudofsky, S. C., Silver, J. M., & Hales, R. E. (1998). Treatment of agitation and aggression. In A. I. Schatzberg & C. B. Nemeroff (Eds.), Textbook of psychopharmacology (pp. 881-900). Washington, DC: American Psychiatric Press.
80. Yudofsky, S. C., Kopecky, H. J., Kunik, M., Silver, J. M., & Endicott, J. (1997). The Overt Agitation Severity Scale for the Objective Rating of Agitation. Journal of Neuropsychiatry, 9, 541-548.
81. Yudofsky, S. C, Silver, J. M., Jackson, W., Endicott, J., & Williams, D. (1986). The Overt Aggression Scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry, 143, 35-39.
82. Yuen, H. K., & Benzing, P. (1996). Guiding of behavior through redirection in brain injury rehabilitation. Journal of Clinical Psychiatry, 10, 229-238.
83. Zayas, E. M., & Grossberg, G. T. (1996). Treating the agitated Alzheimer patient. Journal of Clinical Psychiatry, 57(Suppl. 7), 46-51.
84. Zimmer, J. G., Watson, N., & Treat, A. (1984). Behavioral problems among patients in skilled nursing facilities. American Journal of Public Health, 74, 1118-1121.